SynthesisBMC oral health2026
Clinical efficacy of Lactobacillus plantarum and Lactobacillus brevis as adjuncts to professional mechanical plaque removal in periodontitis: a systematic review.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPeriodontitis is a prevalent chronic inflammatory disease marked by progressive periodontal tissue destruction. It is classified according to the 2017 AAP/EFP staging and grading framework and managed in accordance with the EFP S3-level guideline. Professional mechanical plaque removal (PMPR) remains the cornerstone of non-surgical therapy. However, its limited effectiveness in deep periodontal pockets has prompted interest in adjunctive probiotic approaches. These include Lactobacillus plantarum and Lactobacillus brevis, which exhibit antimicrobial and immunomodulatory properties.
methodsA PRISMA 2020–compliant systematic search of five databases identified randomized controlled trials evaluating L. plantarum and L. brevis as adjuncts to PMPR in periodontitis. The findings were synthesized descriptively.
resultsAdjunctive subgingival delivery of a probiotic gel containing Lactobacillus plantarum and Lactobacillus brevis was associated with significant improvements in PPD, CAL, and IL-10 compared with PMPR alone. In contrast, systemic or combined application showed inconsistent or nonsignificant effects. Clinical benefits were more evident in stage I–II periodontitis, whereas evidence in stage III–IV disease remained inconclusive. DISCUSSION: Three randomized controlled trials were included. While clinical parameters improved following PMPR in all groups, additional benefits from probiotics were observed primarily in early-stage periodontitis with subgingival delivery. Findings in advanced-stage disease were inconsistent and often not statistically significant, suggesting that treatment response may depend on disease stage and delivery method.
conclusionAdjunctive subgingival application of Lactobacillus plantarum and Lactobacillus brevis may offer short-term clinical benefits, particularly in stage I–II periodontitis. However, evidence in stage III–IV remains inconsistent and often not statistically significant. Given the limited number of heterogeneous trials, further well-designed studies are needed to establish their clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.